Stock Price Movement and Market Context
On 22 December 2025, Entero Healthcare Solutions recorded its lowest price in the past year at Rs.956.4. This new low follows a sequence of four consecutive days of price declines, although the stock showed a modest gain on the day it hit this level, with a day change of 0.67%. Despite this slight recovery, the stock continues to trade below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward pressure.
In contrast, the broader market has demonstrated resilience. The Sensex opened 216.54 points higher and further climbed by 230.13 points to close at 85,376.03, representing a 0.53% gain. The Sensex remains close to its 52-week high of 86,159.02, just 0.92% away, supported by bullish moving averages where the 50-day moving average is positioned above the 200-day moving average. Small-cap stocks have led the market rally, with the BSE Small Cap index gaining 0.69% on the same day.
Performance Comparison and Historical Returns
Over the last year, Entero Healthcare Solutions has recorded a return of -31.46%, a stark contrast to the Sensex’s 9.40% gain during the same period. The stock’s 52-week high was Rs.1,564.95, highlighting the extent of the decline to the current low. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index over the past three years, one year, and three months.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Position for Explosive Growth →
Financial Metrics and Operational Highlights
Despite the stock’s price challenges, Entero Healthcare Solutions has demonstrated notable financial metrics. The company’s net sales have grown at an annual rate of 30.10%, with operating profit expanding at a rate of 127.38%. The most recent quarterly results show net sales reaching Rs.1,570.95 crore, the highest recorded, alongside a PBDIT of Rs.62.06 crore and an operating profit margin of 3.95% relative to net sales.
The company has reported positive results for seven consecutive quarters, reflecting consistent profitability. Its return on capital employed (ROCE) stands at 8.6%, and the enterprise value to capital employed ratio is 2.2, suggesting a valuation that is attractive relative to peers’ historical averages. Over the past year, profits have risen by 142%, even as the stock price has declined, resulting in a price-to-earnings-to-growth (PEG) ratio of 0.3.
Debt and Institutional Holdings
Entero Healthcare Solutions maintains a low debt burden, with a Debt to EBITDA ratio of 1.33 times, indicating a strong capacity to service its debt obligations. Institutional investors hold 24.32% of the company’s shares, a level that reflects significant participation by entities with extensive analytical resources.
Entero Healthcare Solutions or something better? Our SwitchER feature analyzes this small-cap Retailing stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Industry Positioning
Operating within the retailing industry and sector, Entero Healthcare Solutions faces a competitive environment where broader market indices have shown strength. The stock’s current valuation and price movement reflect a divergence from the general market trend, with the Sensex and small-cap indices exhibiting upward momentum while the stock trades near its annual low.
The stock’s trading below all major moving averages suggests that it remains under pressure relative to its historical price levels. This technical positioning is a key factor in understanding the stock’s current market behaviour.
Summary of Key Price and Performance Data
To summarise, Entero Healthcare Solutions’ stock price has reached Rs.956.4, its lowest point in the last 52 weeks, following a period of sustained decline. The stock’s one-year return stands at -31.46%, contrasting with the Sensex’s positive 9.40% return. The company’s financial results show growth in sales and profits, alongside a manageable debt profile and significant institutional ownership.
While the broader market continues to advance, Entero Healthcare Solutions remains positioned at a challenging price level, reflecting a complex interplay of sector dynamics and company-specific factors.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
